Prothena Corp (PRTA): Operatsion rentabellik

Prothena Corporation PLC (PRTA) kompaniyasining korporativ logotipi

GURU.Markets saytidagi EBIT marjasi grafigi daromadlilik tendentsiyalarini aks ettiradi, bunda -73.00 darajasi joriy qiymatni ifodalaydi. Prothena Corporation (PRTA) neyrodegeneratsiya terapiyasi sohasida yuqori nufuzga ega, bu esa aksiyadorlarning ishonchini mustahkamlaydi. Biroq, global mojarolar va logistik murakkabliklar xalqaro sinovlar hamda xomashyo ta’minotiga to‘sqinlik qilmoqda. Innovatsiyalarni rivojlantirish Altsgeymer kasalligiga qarshi kurashish uchun sog‘liqni saqlash gigantlari bilan strategik ittifoqlarga tayanadi.

Prothena (PRTA): Operatsion foyda marjasi 04.07.2022dan 19.11.2026gacha

Prothena Biosciences - tahliliy kesimlar va asosiy koʻrsatkichlar (PRTA)

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:prothena.com
Prothena Corp asosiy tovari

Neyrodegenerativ patologiyalar uchun terapiya vositalarini ishlab chiqish ulkan ilmiy risklar va kuchli raqobat bosimini keltirib chiqaradi. Bunday sharoitda, operatsion marja modeli tushumga nisbatan tadqiqot va ishlanmalar (R&D) xarajatlarini boshqarish samaradorligini aks ettiradi. Ushbu ko'rsatkich soliqlar va foizlar to'lanishidan oldingi operatsion foyda ulushini belgilab, asosiy biznesning haqiqiy daromadliligini ochib beradi. Ushbu nisbatning pasayishi kredit risklarining ortishidan dalolat beradi. Tarixiy operatsion marjani tahlil qilish Prothena Corporation (PRTA) moliyaviy barqarorligini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Sotuvning operatsion marjasi BIIB|NBIX: Operatsion foyda normasi|Operatsion rentabellik Regencell Bioscience Ltd (RGC)|Operatsion marja axsome.com (AXSM)|Operatsion marja ACAD (acadia-pharm.com)|XENE - Sotuvning operatsion marjasi|vikingtherapeutics.com - Operatsion marja|Supernus Pharma (SUPN) - Sotuvning operatsion marjasi|CPRX: Operatsion marja|Denali Therapeutics Inc. (DNLI) - Operatsion marja|Operatsion rentabellik Harmony Pharma|Operatsion rentabellik BHVN|Sotuvning operatsion marjasi AMLX (Amylyx Pharmaceuticals, Inc.)|Sotuvning operatsion marjasi Trevi Corp TRVI|Operatsion rentabellik praxismedicines.com PRAX|AVXL - Sotuvning operatsion marjasi|CeriBell EEG - Operatsion marja|ALEC - Operatsion marja|Annexon Inc. (ANNX) - Operatsion rentabellik|Sotuvning operatsion marjasi Omeros Corp|Sotuvning operatsion marjasi NGNE|ACIU: Operatsion foyda normasi|Sotuvning operatsion marjasi VYGR (Voyager Corp)|Sotuvning operatsion marjasi Neumora NMRA|Operatsion rentabellik Scilex Holding Company, Inc. SCLX|Operatsion foyda bo'yicha marjinallik Tevogen Bio Inc.|ACOG - Operatsion rentabellik|Operatsion foyda bo'yicha marjinallik Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Sotuvning operatsion marjasi|Cassava Sciences Inc (SAVA) - Operatsion marja|Sotuvning operatsion marjasi ASRT|Operatsion marja coyatherapeutics.com|Operatsion marja VTGN|Ovid Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Sotuvning operatsion marjasi|ATHE - Operatsion rentabellik|Operatsion faoliyat rentabelligi clene.com CLNN|PEPG: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi JUNS|RLMD (Relmada Corp) - Operatsion marja|Annovis Bio Inc (ANVS) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operatsion foyda normasi|Operatsion rentabellik Klotho Neurosciences KLTO|NRSN: Operatsion foyda bo'yicha sotuv rentabelligi|RVPH: Sotuvning operatsion marjasi|MTVA: Operatsion rentabellik|NRXS (NeurAxis Inc) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Helius Medical Technologies, Inc.|Operatsion rentabellik Passage Bio Inc.|Sotuvning operatsion rentabelligi bionomics.com.au NEUP|Operatsion marja NERV|Operatsion marja Athira Pharma Inc (ATHA)|Operatsion marja ADXN (Addex Therapeutics Ltd.)|ALZN: Operatsion foyda bo'yicha sotuv rentabelligi|CYCN - Operatsion rentabellik|Sotuvning operatsion rentabelligi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha marjinallik Cortigent, Inc. CRGT|Operatsion rentabellik Avenue Therapeutics, Inc.|Sotuvning operatsion marjasi BrainStorm Cell Therapeutics Inc. (BCLI)|Operatsion rentabellik Cara Therapeutics, Inc (CARA)|Operatsion rentabellik CHRO (Chromocell Therapeutics Corp.)|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi